These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 22335800)
21. Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice. Borrego B; Rodríguez-Pulido M; Mateos F; de la Losa N; Sobrino F; Sáiz M Vaccine; 2013 Sep; 31(40):4375-81. PubMed ID: 23859841 [TBL] [Abstract][Full Text] [Related]
22. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response. Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486 [TBL] [Abstract][Full Text] [Related]
23. Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge. Chen SP; Lee MC; Sun YF; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR; Ellis TM Vaccine; 2007 May; 25(22):4464-9. PubMed ID: 17445957 [TBL] [Abstract][Full Text] [Related]
24. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine. Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799 [TBL] [Abstract][Full Text] [Related]
25. Increased humoral antibody response of foot-and-mouth disease virus vaccine in growing pigs pre-treated with poly-γ-glutamic acid. Lee JH; Kang IJ; Kim AR; Noh YS; Chung HC; Park BK J Vet Sci; 2016 Jun; 17(2):253-6. PubMed ID: 26645341 [TBL] [Abstract][Full Text] [Related]
27. Adjuvant effect of Cliptox on the protective immune response induced by an inactivated vaccine against foot and mouth disease virus in mice. Batista A; Quattrocchi V; Olivera V; Langellotti C; Pappalardo JS; Di Giacomo S; Mongini C; Portuondo D; Zamorano P Vaccine; 2010 Aug; 28(38):6361-6. PubMed ID: 20637310 [TBL] [Abstract][Full Text] [Related]
28. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine. Quan Z; Qin ZG; Zhen W; Feng XZ; Hong J; Fei ZH Vet Immunol Immunopathol; 2010 Aug; 136(3-4):257-64. PubMed ID: 20394988 [TBL] [Abstract][Full Text] [Related]
29. Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle. Saravanan P; Sreenivasa BP; Selvan RP; Basagoudanavar SH; Hosamani M; Reddy ND; Nathanielsz J; Derozier C; Venkataramanan R Vaccine; 2015 Jan; 33(5):670-7. PubMed ID: 25528522 [TBL] [Abstract][Full Text] [Related]
30. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs. Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133 [TBL] [Abstract][Full Text] [Related]
31. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Li X; Liu R; Tang H; Jin M; Chen H; Qian P Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351 [TBL] [Abstract][Full Text] [Related]
32. Construction of swine-specific CpG motif enriched plasmid and the study of its immunostimulatory effects both in vitro and in vivo. Guo X; Jia H; Yuan W; Zhang Q; Hou S; Sun Y; Zhu G; Zhu H; Sánchez-Vizcaíno JM J Vet Med Sci; 2012 Dec; 74(12):1647-50. PubMed ID: 22814086 [TBL] [Abstract][Full Text] [Related]
33. The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination. Su B; Wang J; Wang X; Jin H; Zhao G; Ding Z; Kang Y; Wang B Vaccine; 2008 Sep; 26(40):5111-22. PubMed ID: 18462845 [TBL] [Abstract][Full Text] [Related]
34. Effects of germanium biotite supplement on immune responses of vaccinated mini-pigs to foot-and-mouth disease virus challenge. Jung M; Park HT; Park JH; Lee KN; Shin SW; Shin MK; Sung KY; Jung YK; Kim B; Yoo HS Immunol Invest; 2015; 44(1):101-12. PubMed ID: 25058651 [TBL] [Abstract][Full Text] [Related]
35. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs. Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640 [TBL] [Abstract][Full Text] [Related]
36. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost. Li Y; Stirling CM; Denyer MS; Hamblin P; Hutchings G; Takamatsu HH; Barnett PV Vaccine; 2008 May; 26(21):2647-56. PubMed ID: 18321615 [TBL] [Abstract][Full Text] [Related]
37. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine. Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705 [TBL] [Abstract][Full Text] [Related]
38. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. Grubman MJ Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996 [TBL] [Abstract][Full Text] [Related]
39. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus. Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848 [TBL] [Abstract][Full Text] [Related]
40. Protection to homologous and heterologous challenge in pigs immunized with vaccine against foot-and-mouth disease type O caused an epidemic in East Asia during 2010/2011. Park JN; Lee SY; Chu JQ; Lee YJ; Kim RH; Lee KN; Kim SM; Tark DS; Kim B; Park JH Vaccine; 2014 Apr; 32(16):1882-9. PubMed ID: 24525017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]